Tadocizumab Biosimilar (Integrin a2b3 (ITGA2 & ITGB3) Reference Antibody)
Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research.
Product Specifications
Target
Tadocizumab Biosimilar (Anti-Integrin a2b3 (ITGA2 & ITGB3) Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Neuroscience; Immunology & Inflammation
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![[Tyr9]- ß-MSH (porcine) ; (Tyr49) -ß-Lipotropin (41-58) (porcine) [Asp-Glu-Gly-Pro-Tyr-Lys-Met-Glu-Tyr-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp; MW 2202.43]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
SP-101849-1 1 mg
[Tyr9]- ß-MSH (porcine) ; (Tyr49) -ß-Lipotropin (41-58) (porcine) [Asp-Glu-Gly-Pro-Tyr-Lys-Met-Glu-Tyr-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp; MW 2202.43]
Sign In for Pricing
View Details 
